Tattoo Removal on Darker and Olive Skin

What the Fitzpatrick scale is and why it matters for removal

The Fitzpatrick scale is a six-point classification system for skin phototype, developed by dermatologist Thomas Fitzpatrick in 1975. It classifies skin by its response to ultraviolet light: Fitzpatrick type I is very fair skin that always burns and never tans; Fitzpatrick type VI is deeply pigmented skin that never burns.

For tattoo removal, the scale matters because it describes how much melanin a given skin type carries in the epidermis, the outermost layer of skin. Melanin is the same chromophore that laser energy is designed to target in pigmented treatments. In tattoo removal, the target is the tattoo ink; in the epidermis above the ink, melanin is an innocent bystander that can absorb energy meant for the deeper pigment.

The higher the Fitzpatrick type, the more epidermal melanin there is, and the more important the operator's wavelength choice, energy calibration, and spacing decisions become. This is not an insurmountable barrier to safe removal, it is a clinical variable that a well-equipped and trained clinic manages as part of standard protocol.

Why 1064 nm is recognised as the safest wavelength for darker skin

The Q-Switched Nd:YAG laser operates primarily at 1064 nm. This wavelength is recognised in the clinical literature as the safest wavelength for laser tattoo removal on darker skin types, not because it ignores melanin entirely, but because its longer wavelength results in significantly lower melanin absorption relative to shorter wavelengths such as 532 nm, 755 nm, or 585 nm.

The physics: shorter wavelengths are preferentially absorbed by melanin. A laser at 532 nm (green light) is absorbed by melanin at a substantially higher rate than one at 1064 nm (near-infrared). For a patient with Fitzpatrick type IV, V, or VI skin, a treatment at shorter wavelengths carries a higher risk of epidermal thermal injury, collateral heating of the melanin-rich epidermis above the ink target. That injury can present as hyperpigmentation (darkening of the skin post-treatment), hypopigmentation (lightening of the skin, sometimes permanent), or at the extreme end, textural change or scarring.

At 1064 nm, the melanin absorption is lower, which means the energy travels more selectively to the deeper ink target with less collateral epidermal heating. This does not make 1064 nm zero-risk on very deeply pigmented skin. It means the risk profile is the most favourable of any wavelength used for tattoo removal, and that the 1064 nm Q-Switched Nd:YAG platform has the clinical evidence base to support this.

What FDA clearance for all skin types actually means in practice

The Fotona StarWalker MaQX is FDA-cleared for tattoo removal across all skin types, Fitzpatrick I through VI, at 1064 nm in PICO mode.

That is the verbatim scope of the clearance from FDA 510(k) K202172. It is tied specifically to the 1064 nm wavelength in PICO mode. The StarWalker MaQX is the platform Pink uses for tattoo removal, and the FDA clearance for Fitzpatrick I through VI is one of the foundations of Pink's ability to treat the full range of skin types.

FDA clearance is a regulatory fact about a device: it means the regulator reviewed the evidence submitted for that device and accepted the indication for use as stated. In practical terms: the platform is cleared to treat all Fitzpatrick types at this wavelength, which means the device manufacturer has presented evidence to the FDA that treatment at this wavelength on types I through VI is appropriate. That is a more specific and meaningful basis for safety than a clinic's own claim.

The clinical safety evidence: what the published literature shows

The Fitzpatrick-specific safety question has a peer-reviewed answer. Kirby, Alston, and Chen (2016) published a safety series of 1,041 patients treated with Q-Switched Nd:YAG laser tattoo removal, the largest published safety dataset for this treatment modality. The findings:

• Hypertrophic scarring occurred in 0.28% of the total cohort of 1,041 patients.
• Zero keloids were observed across the entire cohort.
• Among the 38 patients in the cohort with Fitzpatrick types V and VI, the skin types where scarring and pigmentation change risk is highest, there were zero hypertrophic scars and zero keloids.

The FST V–VI sub-cohort is 38 patients, small for definitive sub-group conclusions, and it is cited here at its actual size so the reader can assess it. The zero-scarring finding across this group is clinically meaningful, and it is consistent with the physics of the 1064 nm wavelength and the lower melanin absorption at that frequency. But it is 38 patients, not 380, and it is one series.

What the series establishes clearly is the safety profile of the Q-Switched Nd:YAG 1064 nm platform across the range of Fitzpatrick types, and that the scarring and keloid outcomes at the extreme end of the Fitzpatrick range were no worse than at the lighter end.

The specific risks for darker skin: what to know, and how they are managed

Three specific risk categories are relevant for Fitzpatrick IV–VI patients:

Post-inflammatory hyperpigmentation (PIH). After any laser treatment, the skin's inflammatory response can trigger a darkening of the treated area through melanin upregulation. This is more common on darker skin types because of their higher baseline melanin activity. PIH is not a scar, it is a pigmentation change that is typically temporary and manageable. At Pink, calibration decisions that affect PIH risk, energy, spacing, the decision about when the skin has healed sufficiently for the next session, are made per patient and per session.

Hypopigmentation. The reverse effect: lightening of the treated skin. Hypopigmentation occurs when the laser energy affects melanin-producing cells (melanocytes) in the skin. At 1064 nm and appropriate energy calibration, hypopigmentation risk is low; it is more commonly associated with shorter wavelengths or with over-treatment at any wavelength. On very deeply pigmented skin (Fitzpatrick V–VI), the contrast between hypopigmented and surrounding skin can be more visible, which is why conservative calibration on these patients is not a compromise, it is the clinical protocol.

Textural change. Aggressive treatment on darker skin can cause textural changes in the epidermis. Well-calibrated 1064 nm treatment at appropriate energies, with sufficient spacing between sessions for the skin to recover, carries low textural risk. The cadence decision between sessions is part of how this risk is managed.

Calibration is operator skill. The platform provides the wavelength; the clinician makes the energy and spacing decisions that keep the treatment safe and effective. This is the moat the Q-Switched Nd:YAG platform and Pink's operator training build on together.

What to ask a clinic before booking, if you have darker or olive skin

The questions that distinguish a clinic equipped for your skin type from one that isn't:

Does the clinic's platform have FDA clearance for all Fitzpatrick types? The StarWalker MaQX is FDA-cleared for Fitzpatrick I through VI at 1064 nm in PICO mode. Any clinic treating FST V–VI patients with a platform that lacks this clearance is operating outside the cleared indication for that device.

What wavelength does the clinic use for darker skin? The answer should be 1064 nm. Shorter wavelengths carry higher melanin absorption risk and are not the clinical standard for darker skin types.

Does the clinic do a calibration assessment or test patch before committing to full treatment? On higher Fitzpatrick types, especially for first-time patients, a calibration run at lower energy before the full treatment is a clinical practice that manages the PIH and hypopigmentation risk categories above.

Does the clinician make cadence decisions per session, or on a fixed schedule? The skin's response to each session should inform how the next session is spaced. A fixed "come back in six weeks" cadence regardless of the skin's observed response is a less-calibrated protocol.

Book a free consultation at Pink's Doncaster clinic. If you have questions specific to your skin type and your tattoo, the consultation is where those are answered by a clinician reading both in person.

Frequently Asked Questions

Is laser tattoo removal safe on darker or olive skin, is there a real risk of scarring?

The clinical evidence says yes, it can be done safely, with the right platform and calibrated protocol. A peer-reviewed safety series of 1,041 patients treated with Q-Switched Nd:YAG laser tattoo removal (Kirby et al., 2016) found hypertrophic scarring in 0.28% of the full cohort and zero scarring among the 38 Fitzpatrick type V and VI patients in the study. That FST V–VI sub-cohort is 38 patients, cited at its actual size so the reader can assess the weight of the finding. The platform matters: 1064 nm Q-Switched Nd:YAG is the wavelength the clinical literature endorses for darker skin. Shorter wavelengths carry higher melanin absorption and a less favourable risk profile.

What does FDA clearance for "all skin types" actually mean in practice?

The StarWalker MaQX is FDA-cleared for tattoo removal across all skin types, Fitzpatrick I through VI, at 1064 nm in PICO mode. That is the verbatim clearance scope from FDA 510(k) K202172. In practice, it means the FDA reviewed the evidence submitted for this device and accepted that treatment at the 1064 nm wavelength in PICO mode is appropriate for all Fitzpatrick types. It does not mean any Q-Switched treatment at any wavelength on any platform is cleared for all skin types. The clearance is wavelength-specific and device-specific.

Why is 1064 nm considered the better wavelength for darker skin tones?

The 1064 nm wavelength has lower melanin absorption relative to shorter laser wavelengths. Melanin in the epidermis above the tattoo ink can absorb laser energy that is meant for the deeper pigment. This is the mechanism behind the risk of epidermal thermal injury and pigmentation changes on darker skin. At 1064 nm, this competitive absorption is significantly reduced compared to wavelengths such as 532 nm. The result is more selective targeting of the ink with less collateral effect on the melanin-rich epidermis. This is why 1064 nm is recognised in the clinical literature as the safest wavelength for darker skin. Not uniquely safe, but the most favourable of the wavelengths used for tattoo removal.

What is the Fitzpatrick scale and why does it matter for tattoo removal?

The Fitzpatrick scale is a six-point classification of skin phototype, from type I (very fair, always burns) to type VI (deeply pigmented, never burns). For tattoo removal, it matters because it describes the epidermal melanin load, higher Fitzpatrick types have more melanin in the epidermis, which means the wavelength choice, energy calibration, and session spacing become more important variables in safe treatment. The scale is also what FDA device clearances are referenced to: the StarWalker MaQX's FST I–VI clearance is the regulatory expression of the same skin-type calibration that drives the clinical protocol.

How does the risk of pigmentation changes apply to me if I have olive or brown skin?

Post-inflammatory hyperpigmentation (darkening of the treated area after laser treatment) is more common on Fitzpatrick IV–VI skin because of higher baseline melanin activity. Hypopigmentation (lightening of treated skin) is less common but carries a more visible contrast effect on deeper skin tones. Both risks are reduced, not eliminated, by using the right wavelength and appropriate energy calibration. At Pink, cadence decisions between sessions and energy calibration within sessions are made per patient and per session to manage these specific risks. If either effect does occur, it is typically manageable and, in the case of PIH, often temporary.

What questions should I ask a clinic to know if they are equipped to treat my skin type safely?

The key questions: Does your platform have FDA clearance for Fitzpatrick I–VI? (The StarWalker MaQX does, at 1064 nm in PICO mode.) What wavelength do you use for Fitzpatrick IV–VI skin? (The answer should be 1064 nm.) Do you do a calibration assessment or test patch before full treatment on higher Fitzpatrick types? Do you make cadence decisions per session based on the skin's response, or on a fixed schedule? These questions produce more clinically relevant information than "do you treat dark skin?", which any clinic can say yes to.

Book Your Free Consultation

If you have olive, brown, or deeper skin and are considering tattoo removal, the consultation is where the Fitzpatrick-specific clinical picture becomes specific to your tattoo and your skin. Pink treats Fitzpatrick types I through VI, for both body and eyebrow tattoo removal.

Book your free consultation (opens in a new tab).

For the full treatment picture, see Pink's tattoo removal page.